These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26245656)

  • 1. Immunohistochemical expression of 8-oxo-7,8-dihydro-2'-deoxyguanosine in cytoplasm of tumour and adjacent normal mucosa cells in patients with colorectal cancer.
    Matosevic P; Klepac-Pulanic T; Kinda E; Augustin G; Brcic I; Jakic-Razumovic J
    World J Surg Oncol; 2015 Aug; 13():241. PubMed ID: 26245656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
    Nakazawa T; Goi T; Hirono Y; Yamaguchi A
    Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear oxidative damage correlates with poor survival in colorectal cancer.
    Sheridan J; Wang LM; Tosetto M; Sheahan K; Hyland J; Fennelly D; O'Donoghue D; Mulcahy H; O'Sullivan J
    Br J Cancer; 2009 Jan; 100(2):381-8. PubMed ID: 19066606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
    Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
    Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
    Yuan H; Tu SL; He XJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
    Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
    Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of HLA class I expression in patients with colorectal cancer.
    Iwayama Y; Tsuruma T; Mizuguchi T; Furuhata T; Toyota N; Matsumura M; Torigoe T; Sato N; Hirata K
    World J Surg Oncol; 2015 Feb; 13():36. PubMed ID: 25889416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor expression is correlated with survival of patients with colorectal cancer.
    Wei SC; Tsao PN; Yu SC; Shun CT; Tsai-Wu JJ; Wu CH; Su YN; Hsieh FJ; Wong JM
    Gut; 2005 May; 54(5):666-72. PubMed ID: 15831913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancer.
    Ljuslinder I; Melin B; Henriksson ML; Öberg Å; Palmqvist R
    Int J Cancer; 2011 May; 128(9):2031-7. PubMed ID: 20635387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
    Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
    Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.
    Nebiker CA; Han J; Eppenberger-Castori S; Iezzi G; Hirt C; Amicarella F; Cremonesi E; Huber X; Padovan E; Angrisani B; Droeser RA; Rosso R; Bolli M; Oertli D; von Holzen U; Adamina M; Muraro MG; Mengus C; Zajac P; Sconocchia G; Zuber M; Tornillo L; Terracciano L; Spagnoli GC
    Clin Cancer Res; 2014 Jun; 20(12):3094-106. PubMed ID: 24737547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin expression and its prognostic value for colorectal cancer.
    Li Z; Zhang X; Yang Y; Yang S; Dong Z; Du L; Wang L; Wang C
    Int J Mol Sci; 2015 May; 16(6):12108-18. PubMed ID: 26023718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
    Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
    World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
    Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
    Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.